120. Hausermann P, Widmer A, Itin P. Dermatoscope as vector for transmissible diseases-no apparent risk of nosocomial infections in outpatients. Dermatology . 2006;212(1):27-30. 121. Kelly SC, Purcell SM. Prevention of nosocomial infection during dermoscopy? Dermatol Surg . 2006;32(4):552-555. 122. Devine J, Cooke RP, Wright EP. Is methicillin-resistant Staphylococcus aureus (MRSA) contamination of ward-based computer terminals a surrogate marker for nosocomial MRSA transmission and handwashing compliance? J Hosp Infect . 2001;48(1):72-75. 123. Vinh DC, Embil JM. Device-related infections: a review. J Long-Term Effects Med Implants . 2005;15(5):467-488. 124. Harris LG, Richards RG. Staphylococci and implant surfaces: a review. Injury . 2006;37(Suppl 2):S3-S14. 125. Schierholz JM, Beuth J. Implant infections: a haven for opportunistic bacteria. J Hosp Infect . 2001;49(2):87-93. 126. Ling ML, Apisarnthanarak A, Jaggi N, et al. APSIC guide for prevention of central line associated bloodstream infections (CLABSI). Antimicrob Resist Infect Control. 2016;5:16. 127. Pinto H, Simoes M, Borges A. Prevalence and impact of biofilms on bloodstream and urinary tract infections: a systematic review and meta- analysis. Antibiotics . 2021;10:825. 128. Svensson MK, Tillander J, Zaborowska M, et al. Biofilm properties in relation to treatment outcome in patients with first-time periprosthetic hip or knee joint infection. J Orthop Transl . 2021;30:31-40. 129. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control . 2008;36(5):309-332. 130. National Healthcare Safety Network. CDC/NHSN Surveillance Definitions for Specific Types of Infections: 2024. Available at https://www.cdc. gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf. Last accessed January 15, 2025. 131. Calderwood MS, Anderson DJ, Bratzler DW, et al. Strategies to prevent surgical site infections in acute care hospitals: 2022 update. Infect Control Hosp Epidemiol. 2023;44(5):695-720. 132. Mittmann N, Koo M, Daneman N, et al. The economic burden of patient safety targets in acute care: a systematic review. Drug, Healthcare Patient Safe . 2012;4:141-165. 133. Dubberke ER, Butler AM, Yokoe DS, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol . 2010;31(10):1030-1037. 134. Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis . 2012;55(Suppl 2):S88-S92. 135. Mitchell BG, Gardner A. Mortality and Clostridium difficile infection: a review. Antimicrob Resist Infect Control . 2012;1(1):20. 136. McGlone SM, Bailey RR, Zimmer SM, et al. The economic burden of Clostridium difficile . Clin Microbiol Infect . 2012;18(3):282-289. 137. Weber DJ, Sickbert-Bennett EE, Gould CV, Brown VM, Huslage K, Rutala WA. Incidence of catheter-associated and non-catheter-associated urinary tract infections in a healthcare system. Infect Control Hosp Epidemiol . 2011;32:822-823. 138. Falagas ME, Kompoti M. Obesity and infection. Lancet Infec Dis . 2006;6(7):438-446. 139. Chen HS, Wang FD, Lin M, Lin YC, Huang LJ, Liu CY. Risk factors for central venous catheter-related infections in general surgery. J Microbiol Immunol Infect . 2006;39(3):231-236. 140. Mukhtar RA, Throckmorton AD, Alvarado MD, et al. Bacteriologic features of surgical site infections following breast surgery. Am J Surg . 2009;198(4):529-531. 141. Dalstrom DJ, Venkatarayappa I, Manternach AL, Palcic MS, Heyse BA, Prayson MJ. Time-dependent contamination of opened sterile operating- room trays. J Bone Joint Surg Am . 2008;90(5):1022-1025. 142. de Wit M, Goldberg S, Hussein E, Neifeld JP. Health care-associated infections in surgical patients undergoing elective surgery: are alcohol use disorders a risk factor? J Am Coll Surg . 2012;215(2):229-236. 143. Qaseem A, Snow V, Fitterman N, et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med . 2006;144(8):575-580. current 144. Eom C-S, Jeon CY, Cho E-G, Park SM, Lee K-S. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis. CMAJ . 2011;183(3):310-319. 145. Merle V, Hallais C, Tavolacci MP, et al. Validity of medical staff assessment at admission of patient’s risk of nosocomial infection: a prospective study in a surgical intensive care unit. Intensive Care Med . 2006;32(6):915-918. 146. Centers for Disease Control and Prevention. Healthcare-Associated Infections. HAI Pathogens and Antimicrobial Resistance Report, 2018-2021. Available at https://www.cdc.gov/nhsn/hai-report/data-tables-adult/index.html. Last accessed January 15, 2025. 147. Dudeck MA, Edwards JR, Allen-Bridson K, Gross Cet al. National Healthcare Safety Network (NHSN) report, data summary for 2013, device- associated module. Am J Infect Cont . 2015;43(3):206-221. 148. Institute for Healthcare Improvement. How-to Guide: Prevent Catheter-Associated Urinary Tract Infections. Available at https://www.urotoday. com/images/catheters/pdf/IHIHowtoGuidePreventCAUTI.pdf. Last accessed January 15, 2025. 149. Wald HL, Ma A, Bratzler DW, et al. Indwelling urinary catheter use in the postoperative period: analysis of the National Surgical Infection Prevention Project data. Arch Surg . 2008;143(6):551-557. 150. Huang SS. Catheter-associated urinary tract infection: turning the tide. N Engl J Med . 2016;374(22):2168-2169. 151. Srinivasan A, Karchmer T, Richards A, Song X, Perl TM. A prospective trial of a novel, silicone-based, silver-coated Foley catheter for the prevention of nosocomial urinary tract infections. Infect Control Hosp Epidemiol . 2006;27(1):38-43. 152. Johnson JR, Kuskowski MA, Witt TJ. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann Intern Med . 2006;144(2):116-126.
Powered by FlippingBook